Nima Firouzeh

Dr. Nima Firouzeh

Vector-Borne Disease Research Center, North Khorasan University of Medical Sciences, Bojnurd, Iran, Bojnourd, Iran
orcid

Research Focus & Metrics

Academic Career Length

8Years (2019-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
29 July 2019 in Clean Technologies and Environmental Policy
Verified
Journal Article
Closed access
PDF file
MMMahammad Malakotian
Mahammad Malakotian
SASeyedeh Nastaran Asadzadeh
Seyedeh Nastaran Asadzadeh
MKMehrdad Khatami
Mehrdad Khatami
MAMohammad Ahmadian
Mohammad Ahmadian
MHMohammad R. Heidari
Mohammad R. Heidari
Rajender S. VarmaRajender S. Varma
Rajender S. Varma

30 January 2021 in BioNanoScience
Verified
Journal Article
Closed access
PDF file
NFNima Firouzeh
Nima Firouzeh
MMMohammad Malakootian
Mohammad Malakootian
NAnastaran asadzadeh
nastaran asadzadeh
MKMehrdad Khatami
Mehrdad Khatami
ZMZohre Makarem
Zohre Makarem

4 July 2020 in Journal of Parasitic Diseases
Verified
Journal Article
Closed access
PDF file
AAArash Asadi
Arash Asadi
AKAmir Tavakoli kareshk
Amir Tavakoli kareshk
ISIraj Sharifi
Iraj Sharifi
NFNima Firouzeh
Nima Firouzeh

18 March 2024 in Journal of Ultrasound in Medicine
Verified
Journal Article
Closed access
PDF file
RSReza Shafiei
Reza Shafiei
MMMina Sadat Mohajerzadeh
Mina Sadat Mohajerzadeh
HMHajar Farah Abad Masomi
Hajar Farah Abad Masomi
MTMaryam Tavakoli
Maryam Tavakoli
HTHabibollah Turki
Habibollah Turki
NFNima Firouzeh
Nima Firouzeh

5 July 2020 in Journal of Parasitic Diseases
Verified
Journal Article
Closed access
PDF file
AFAshkan Faridi
Ashkan Faridi
AKAmir Tavakoli kareshk
Amir Tavakoli kareshk
SSSaeed Sadooghian
Saeed Sadooghian
NFNima Firouzeh
Nima Firouzeh

15 December 2024 in Tropical Diseases, Travel Medicine and Vaccines
Verified
Journal Article
Open access
PDF file
EIElham Isaei
Elham Isaei
MSMohammad Hossein Sobhanipoor
Mohammad Hossein Sobhanipoor
MRMehran Rahimlou
Mehran Rahimlou
NFNima Firouzeh
Nima Firouzeh
Tuberculosis represents a significant menace to health, leading to millions of cases and fatalities each year. Traditional diagnostic methods, while effective, have limitations, necessitating improved tools. Aptamers possessing remarkable specificity single-stranded DNA or RNA molecules promising in TB diagnosis due to their adaptability and precise biomarker detection capabilities. In this study, we aimed to evaluate the research on aptamer applications in TB diagnosis, evaluating the efficacy, limitations, and future prospects. The present systematic review study followed PRISMA guidelines, including peer-reviewed studies on aptamer efficacy in TB diagnosis. Eligibility criteria covered experimental and human studies on TB diagnosis, prognosis, progression, and treatment response. Of 1165 identified studies, 35 met inclusion criteria. Aptamers were utilized for MTB and mycobacterial antigen detection, showcasing notable sensitivity and specificity. Targeted antigens included ESAT-6, HspX, MPT 64, and IFN-γ. Various aptamer-based assays, such as electrochemical, fluorescent, and immunosensors, demonstrated effectiveness. Multiplex assays, particularly for IFN-γ, showed enhanced diagnostic accuracy. Aptamer-based assays exhibited discrimination between active TB and other conditions, showcasing their diagnostic value. Aptamers, especially in conjunction with nanomaterials, show promise in developing advanced TB biosensors with superior detection capabilities. Cost-effective devices with heightened sensitivity for clinical and screening use are crucial for TB control, emphasizing the need for ongoing research in this field.